These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14746758)

  • 21. Technetium 99m dimercaptosuccinic acid scintigraphy in medullary carcinoma of the thyroid.
    Scher RL; Eisele DW; Sostre S
    Ann Otol Rhinol Laryngol; 1993 Nov; 102(11):900-3. PubMed ID: 8239354
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of bisphosphonates with calcitonin in monitoring medullary carcinoma of the thyroid.
    Osborne ME; Brown RS; Hoskin PJ
    Clin Oncol (R Coll Radiol); 2001; 13(5):370-1. PubMed ID: 11716232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma eats medullary thyroid carcinoma, a case of tumor-in-tumor metastasis.
    Sung TY; Lee SR; Lee JH; Lee YM; Lee AL; Hwang DW; Yoon JH; Gong G; Hong SJ; Park KM
    Endocr J; 2011; 58(9):801-5. PubMed ID: 21757828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late liver metastasis of medullary thyroid cancer with low calcitonin levels - successfully cured by radiofrequency.
    Al-Salameh A; Baudry C; Gautier JF; Toubert ME; Bihan H; Cohen R
    Endokrynol Pol; 2016; 67(3):326-9. PubMed ID: 26884307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medullary thyroid carcinoma.
    Evans DB; Burgess MA; Goepfert H; Gagel RF
    Curr Ther Endocrinol Metab; 1997; 6():127-32. PubMed ID: 9174720
    [No Abstract]   [Full Text] [Related]  

  • 27. Somatostatin receptor imaging in persistent medullary thyroid carcinoma.
    Frank-Raue K; Bihl H; Dörr U; Buhr H; Ziegler R; Raue F
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):31-7. PubMed ID: 7889629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.
    Learoyd DL; Roach PJ; Briggs GM; Delbridge LW; Wilmshurst EG; Robinson BG
    J Nucl Med; 1997 Feb; 38(2):227-30. PubMed ID: 9025742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Familial medullary carcinoma of the thyroid. The usefulness of ultrasonography and Doppler color].
    Fernández García P; Cervera Deval J; Marco Doménech SF; Laguna Sastre M
    Rev Clin Esp; 1998 Nov; 198(11):745-8. PubMed ID: 9883048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer.
    Tung WS; Vesely TM; Moley JF
    Surgery; 1995 Dec; 118(6):1024-9; discussion 1029-30. PubMed ID: 7491518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201.
    Adalet I; Demirkale P; Unal S; Oůz H; Alagöl F; Cantez S
    Clin Nucl Med; 1999 Sep; 24(9):678-83. PubMed ID: 10478744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medullary carcinoma of the thyroid: subtypes and current management.
    Randolph GW
    Compr Ther; 1996 Apr; 22(4):203-10. PubMed ID: 8733776
    [No Abstract]   [Full Text] [Related]  

  • 33. Fine needle aspiration biopsy of medullary carcinoma of the thyroid metastatic to the liver. A case report.
    Payn J; Yazdi HM
    Acta Cytol; 1993; 37(6):953-6. PubMed ID: 8249519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
    Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed medullary-follicular thyroid carcinoma. Report of a case and review of the literature.
    Kostoglou-Athanassiou I; Athanassiou P; Vecchini G; Gogou L; Kaldrymides P
    Horm Res; 2004; 61(6):300-4. PubMed ID: 15153799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic medullary thyroid carcinoma in liver diagnosis by aspiration cytology.
    Gomez-Fernandez C; Kraemer HJ; Ganjei P
    Diagn Cytopathol; 1994; 11(3):277-80. PubMed ID: 7867472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
    Giraudet AL; Vanel D; Leboulleux S; Aupérin A; Dromain C; Chami L; Ny Tovo N; Lumbroso J; Lassau N; Bonniaud G; Hartl D; Travagli JP; Baudin E; Schlumberger M
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4185-90. PubMed ID: 17726071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medullary carcinoma of the thyroid with calcified metastases].
    Hörmann M; Hackl A; Schneider G
    Rofo; 1985 Jul; 143(1):118-20. PubMed ID: 2992005
    [No Abstract]   [Full Text] [Related]  

  • 39. Medullary thyroid carcinoma with multiple hepatic metastases: treatment with transcatheter arterial embolization and percutaneous ethanol injection.
    Isozaki T; Kiba T; Numata K; Saito S; Shimamura T; Kitamura T; Morita K; Tanaka K; Sekihara H
    Intern Med; 1999 Jan; 38(1):17-21. PubMed ID: 10052736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoldering medullary thyroid carcinoma liver metastasis 37 years after resection of an organ-confined tumor.
    Waters KM; Ali SZ; Erozan YS; Olson MT
    Diagn Cytopathol; 2015 Jan; 43(1):45-8. PubMed ID: 24550155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.